← Back to Clinical Trials
Recruiting NCT07098884

NCT07098884 Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07098884
Status Recruiting
Phase —
Sponsor Anhui Provincial Hospital
Condition Artificial Intelligence
Study Type OBSERVATIONAL
Enrollment 600 participants
Start Date 2025-06-01
Primary Completion 2025-10-30

Trial Parameters

Condition Artificial Intelligence
Sponsor Anhui Provincial Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 600
Sex ALL
Min Age 20 Years
Max Age 75 Years
Start Date 2025-06-01
Completion 2025-10-30
Interventions
AI model

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The current study aims to develop and validate a deep learning signature for diagnosing pathology and predicting prognosis of lung nodule using smartphone photos of resected tumor specimens.

Eligibility Criteria

Inclusion Criteria: (1) Participants scheduled for surgery for radiological finding of pulmonary lesions from the preoperative thin-section CT scans; (2) Age ranging from 20-75 years. Exclusion Criteria: (1) Participants with incomplete clinical information; (2) Participants who have received anti-tumor therapy.

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE ARTIFICIAL INTELLIGENCE TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology